Expression of metallothionein in ameloblastoma. A regulatory molecule?

Journal of Oral Pathology and Medicine

Volumn 40, Issue 6, 2011, Pages 516-519

  Ribeiro, Andre Luis Ribeiro ^a,b,c   Nobre, Rafaela Moutinho ^c   Rocha, Gabriela Cristina Marçal Avertano ^c   De Souza Lobato, Isabella Haber ^c   De Melo Alves Junior, Sérgio ^a,c   Jaeger, Ruy Gastaldoni ^d   De Jesus Viana Pinheiro, João ^c,d  

^a CENTRO UNIVERSITÁRIO DO ESTADO DO PARÁ   (Brazil)

^b Hospital Metropolitano de Urgência e Emergência   (Brazil)

^c FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Ameloblastoma; Matrix metalloproteinases; Metallothionein; Odontogenic tumor; Oral pathology

Indexed keywords

METALLOTHIONEIN;

AMELOBLASTOMA; ARTICLE; CANCER INVASION; COLUMNAR EPITHELIUM; CONTROLLED STUDY; DISEASE MARKER; HUMAN; IMMUNOHISTOCHEMISTRY; MORPHOMETRICS; ODONTOGENIC CYST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

AMELOBLASTOMA; CASE-CONTROL STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; METALLOTHIONEIN; NEOPLASM INVASIVENESS; ODONTOGENIC TUMORS; SKIN NEOPLASMS;

EID: 79959969150     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2011.01025.x     Document Type: Article

References (15)

1. Barnes L, Eveson JW, Reichart P, Sidransky D. Pathology and genetics of head and neck tumours (WHO classification of tumours). Lyon: IARC Press, 2005.
2. Kramer IR, Pindborg JJ, Shear M. The WHO histological typing of odontogenic tumours. A commentary on the second edition. Cancer 1992; 70: 2988-94.
3. Reichart PA, Philipsen HP, Sonner S. Ameloblastoma: biological profile of 3677 cases. Eur J Cancer B Oral Oncol 1995; 31B: 86-99.
4. Hong J, Yun PY, Chung IH, et al. Long-term follow up on recurrence of 305 ameloblastoma cases. Int J Oral Maxillofac Surg 2007; 36: 283-8.
5. Olaitan AA, Adeola DS, Adekeye EO. Ameloblastoma: clinical features and management of 315 cases from Kaduna, Nigeria. J Craniomaxillofac Surg 1993; 21: 351-5.
6. Pinheiro JJ, Freitas VM, Moretti AI, Jorge AG, Jaeger RG. Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity. Histopathology 2004; 45: 65-72.
7. Siqueira AS, Carvalho MR, Monteiro AC, Freitas VM, Jaeger RG, Pinheiro JJ. Matrix metalloproteinases, TIMPs and growth factors regulating ameloblastoma behaviour. Histopathology 2010; 57: 128-37.
8. Vasák M, Hasler DW. Metallothioneins: new functional and structural insights. Curr Opin Chem Biol 2000; 4: 177-83.
9. Vasák M. Advances in metallothionein structure and functions. J Trace Elem Med Biol 2005; 19: 13-7.
10. Quaife CJ, Findley SD, Erickson JC, et al. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry 1994; 33: 7250-9.
11. Aguiar MCF, Reis DG, Fonseca LMS, Cardoso SV, Leite JA, Carmo MAV. Immunohistochemical evaluation of metallothionein in palatal mucosal cells of mice treated with 4NQO. Med Oral Patol Oral Cir Bucal 2006; 11: 315-8.
12. Pedersen MØ, Larsen A, Stoltenberg M, Penkowa M. The role of metallothionein in oncogenesis and cancer prognosis. Prog Histochem Cytochem 2009; 44: 29-64.
13. Uozaki H, Horiuchi H, Ishida T, Iijima T, Imamura T, Machinami R. Overexpression of resistance-related proteins (metallothioneins, glutathione-S-transferase pi, heat shock protein 27, and lung resistance-related protein) in osteosarcoma. Relationship with poor prognosis. Cancer 1997; 79: 2336-44.
14. Vallee BL. The function of metallothionein. Neurochem Int 1995; 27: 23-33.
15. Sundelin K, Jadner M, Norberg-Spaak L, Davidsson A, Hellquist HB. Metallothionein and Fas (CD95) are expressed in squamous cell carcinoma of the tongue. Eur J Cancer 1997; 33: 1860-4.